Direct antiviral salvage therapy for hepatitis C—Sofosbuvir/Velpatasvir /Voxilaprevir

doi:10.3969/j.issn.1672-3384.2021.12.005

PDF(420 KB)

Clinical Medication Journal ›› 2021, Vol. 19 ›› Issue (12) : 22-25. DOI: 10.3969/j.issn.1672-3384.2021.12.005

Drug treatment of hepatitis C

Direct antiviral salvage therapy for hepatitis C—Sofosbuvir/Velpatasvir /Voxilaprevir

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 19(12): 22-25 https://doi.org/10.3969/j.issn.1672-3384.2021.12.005

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(420 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2021-08-25	2021-12-24
Issue Date
2021-12-24

Please choose a citation manager

Content to export